199102

Erkek Bir Ergende Metilfenidat ile İndüklenen Hiperhidrozis

Hiperhidrozis (aşırı terleme) dikkat eksikliği ve hiperaktivite bozukluğu nedeniyle metilfenidat tedavisi uygulanan çocuklarda nadiren bildirilmiş bir ilaç yan etkisidir. Dikkat eksikliği ve hiperaktivite bozukluğu tanılı çocuk ve ergenlerde aşırı doz metilfenidat alımına bağlı hiperhidrozis bildirilen birkaç vaka örneği vardır. Bu yazımızda dikkat eksikliği ve hiperaktivite bozukluğunu tedavi için uzun etkili metilfenidat (Concerta®) kullanımı sonrasında hiperhidrozis yan etkisi görülen bir hastayı sunmaktayız.

Methylphenidate-Induced Hyperhidrosis in an Adolescent Boy

Hyperhidrosis (excessive sweating) is a rarely reported side effect of methylphenidate treatment in young subjects with attention-deficit/hyperactivity disorder. There are few reports of hyperhidrosis associated with methylphenidate overdose in children and adolescents with diagnosis of ADHD. Here we report a case of an adolescent boy who developed hyperhidrosis after taking osmotic-controlled release oral delivery system methylphenidate (Concerta®) for his attention-deficit/hyperactivity disorder.

PDF

___

1. The US Food and Drug Administration [Internet]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021121s015s017l.pdf [accessed 22 July 2016].
2. Khajehpiri Z, Mahmoudi-Gharaei J, Faghihi T, Karimzadeh I, Khalili H, Mohammadi M. Adverse reactions of methylphenidate in children with attention deficit-hyperactivity disorder: report from a referral center. J Res Pharm Pract. 2014;3(4):130-6.
3. Hassanian-Moghaddam H, Ranjbar M, Farnaghi F, Zamani N, Alizadeh AM, Sarjami S. Stimulant Toxicity in Children: A Retrospective Study on 147 Patients. Pediatr Crit Care Med. 2015;16(8):290-6.
4. Patel V, Krishna AS, Lefevre C, Kaagaza M, Wittkamp M. Methylphenidate Overdose causing secondary polydipsia and severe hyponatremia in an 8-year-old boy. Pediatr Emerg Care. DOI: 10.1097/PEC.0000000000000788.
5. Green WH. Sympathomimetic amines and central nervous system stimulants. Child and Adolescent Clinical Psychopharmacology, 4. ed. Philadelphia: Lippincott Williams & Wilkins; 2007:55-90.
6. Coskun M, Zoroglu S. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol. 2008;28(6):723-5.
7. Coskun M, Zoroglu S. A report of two cases of sexual side effects with OROS methylphenidate. J Child Adolesc Psychopharmacol. 2009;19(4):477-9.
8. Coskun M, Tutkunkardas MD, Zoroglu S. OROS methylphenidate-induced skin eruptions. J Child Adolesc Psychopharmacol. 2009;19(5):593-4.
9. Kaya I, Coskun M. Diffuse maculopapular rash with increasing dosage of methylphenidate. J Clin Psychopharmacol. 2016;36(1):106-7.
10. Coskun M. Methylphenidate induced obsessive-compulsive symptoms treated with sertraline. Bull Clin Psychopharmacol. 2011;21(3):275-6.
11. Coskun M, Adak I, Akaltun I. Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine. J Clin Psychopharmacol. 2014;34(4):537-8.
12. Coskun M, Kaya I. Painful muscle cramps possibly associated with withdrawal from methylphenidate. J Child Adolesc Psychopharmacol. 2016;26(7):658-9.
13. Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf. 2008;31(2):109-26.
14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.